Search research articles
Contact Us
Filters
Showing results (901-910 of 933) with videos related to
Page
of 94
Sort By:
Science Advances
|
December 8, 2018
Convergent evolution of a metabolic switch between aphid and caterpillar resistance in cereals
B Li, C Förster, C A M Robert, et al.
Nature Communications
|
August 2, 2024
The lactonase BxdA mediates metabolic specialisation of maize root bacteria to benzoxazinoids
Lisa Thoenen, Marco Kreuzer, Christine Pestalozzi, et al.
ESMO Open
|
August 31, 2024
Association of post-operative ctDNA detection with outcomes of patients with early breast cancers
R Cutts, L Ulrich, M Beaney, et al.
The Plant Cell
|
June 19, 2016
Biosynthesis of 8-O-Methylated Benzoxazinoid Defense Compounds in Maize
Vinzenz Handrick, Christelle A M Robert, Kevin R Ahern, et al.
European Journal of Medical Genetics
|
March 23, 2021
Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients
S Nambot, C Sawka, G Bertolone, et al.
The Plant Journal : for Cell and Molecular Biology
|
January 3, 2013
The maize lipoxygenase, ZmLOX10, mediates green leaf volatile, jasmonate and herbivore-induced plant volatile production for defense against insect attack
Shawn A Christensen, Andriy Nemchenko, Eli Borrego, et al.
Research Square
|
September 11, 2023
Associations of cardiometabolic polygenic risk scores with cardiovascular disease in African Americans
Workalemahu Tsegaselassie, Ying Jian, Gebremeskel G Berhanu, et al.
ESMO Open
|
May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
C Baldini, E Charton, E Schultz, et al.
ESMO Open
|
August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
E Charton, C Baldini, Y Fayet, et al.
Pediatrics
|
July 25, 2007
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021
Ross E McKinney, John Rodman, Chengcheng Hu, et al.
Page
of 94
Search research articles
Search
Showing results (901-910 of 933) with videos related to
Sort By:
Page
of 94
Science Advances
|
December 8, 2018
Convergent evolution of a metabolic switch between aphid and caterpillar resistance in cereals
B Li, C Förster, C A M Robert, et al.
Nature Communications
|
August 2, 2024
The lactonase BxdA mediates metabolic specialisation of maize root bacteria to benzoxazinoids
Lisa Thoenen, Marco Kreuzer, Christine Pestalozzi, et al.
ESMO Open
|
August 31, 2024
Association of post-operative ctDNA detection with outcomes of patients with early breast cancers
R Cutts, L Ulrich, M Beaney, et al.
The Plant Cell
|
June 19, 2016
Biosynthesis of 8-O-Methylated Benzoxazinoid Defense Compounds in Maize
Vinzenz Handrick, Christelle A M Robert, Kevin R Ahern, et al.
European Journal of Medical Genetics
|
March 23, 2021
Incidental findings in a series of 2500 gene panel tests for a genetic predisposition to cancer: Results and impact on patients
S Nambot, C Sawka, G Bertolone, et al.
The Plant Journal : for Cell and Molecular Biology
|
January 3, 2013
The maize lipoxygenase, ZmLOX10, mediates green leaf volatile, jasmonate and herbivore-induced plant volatile production for defense against insect attack
Shawn A Christensen, Andriy Nemchenko, Eli Borrego, et al.
Research Square
|
September 11, 2023
Associations of cardiometabolic polygenic risk scores with cardiovascular disease in African Americans
Workalemahu Tsegaselassie, Ying Jian, Gebremeskel G Berhanu, et al.
ESMO Open
|
May 9, 2022
Access to early-phase clinical trials in older patients with cancer in France: the EGALICAN-2 study
C Baldini, E Charton, E Schultz, et al.
ESMO Open
|
August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 study
E Charton, C Baldini, Y Fayet, et al.
Pediatrics
|
July 25, 2007
Long-term safety and efficacy of a once-daily regimen of emtricitabine, didanosine, and efavirenz in HIV-infected, therapy-naive children and adolescents: Pediatric AIDS Clinical Trials Group Protocol P1021
Ross E McKinney, John Rodman, Chengcheng Hu, et al.
Page
of 94